Stuart Weisbrod decreased its stake in Ultragenyx Pharmaceutical In (RARE) by 33.33% based on its latest 2017Q3 regulatory filing with the SEC. Iguana Healthcare Management Llc sold 25,000 shares as the company’s stock declined 25.28% while stock markets rallied. The hedge fund run by Stuart Weisbrod held 50,000 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $2.66 million, down from 75,000 at the end of the previous reported quarter. Iguana Healthcare Management Llc who had been investing in Ultragenyx Pharmaceutical In for a number of months, seems to be less bullish one the $2.21B market cap company. The stock decreased 0.84% or $0.4 during the last trading session, reaching $47.12. About 344,776 shares traded. Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) has declined 6.49% since February 18, 2017 and is downtrending. It has underperformed by 23.19% the S&P500.
Scout Investments Inc increased its stake in Keycorp New (KEY) by 5.23% based on its latest 2017Q3 regulatory filing with the SEC. Scout Investments Inc bought 72,566 shares as the company’s stock declined 6.49% while stock markets rallied. The institutional investor held 1.46 million shares of the major banks company at the end of 2017Q3, valued at $27.47M, up from 1.39 million at the end of the previous reported quarter. Scout Investments Inc who had been investing in Keycorp New for a number of months, seems to be bullish on the $22.47B market cap company. The stock increased 0.33% or $0.07 during the last trading session, reaching $21.02. About 6.81 million shares traded. KeyCorp (NYSE:KEY) has risen 43.10% since February 18, 2017 and is uptrending. It has outperformed by 26.40% the S&P500.
Scout Investments Inc, which manages about $31.17B and $3.65 billion US Long portfolio, decreased its stake in Price T Rowe Group Inc (NASDAQ:TROW) by 4,201 shares to 111,145 shares, valued at $10.08 million in 2017Q3, according to the filing. It also reduced its holding in Prudential Plc (NYSE:PUK) by 40,454 shares in the quarter, leaving it with 587,069 shares, and cut its stake in Oceaneering Intl Inc (NYSE:OII).
Among 34 analysts covering Keycorp (NYSE:KEY), 21 have Buy rating, 2 Sell and 11 Hold. Therefore 62% are positive. Keycorp had 108 analyst reports since July 20, 2015 according to SRatingsIntel. Piper Jaffray initiated KeyCorp (NYSE:KEY) on Tuesday, November 24 with “Overweight” rating. The firm earned “Underweight” rating on Tuesday, January 3 by Barclays Capital. On Thursday, January 25 the stock rating was upgraded by Deutsche Bank to “Buy”. The stock has “Neutral” rating by Piperjaffray on Monday, August 29. The company was initiated on Thursday, August 20 by Sterne Agee CRT. The stock has “Buy” rating by Citigroup on Monday, August 22. On Tuesday, October 25 the stock rating was upgraded by Rafferty to “Buy”. As per Friday, August 25, the company rating was maintained by Piper Jaffray. The firm earned “Buy” rating on Monday, January 8 by Jefferies. The rating was maintained by Robert W. Baird on Tuesday, January 2 with “Hold”.
Since October 24, 2017, it had 1 insider buy, and 3 insider sales for $1.16 million activity. Midkiff Mark W had bought 458 shares worth $9,998. Another trade for 11,819 shares valued at $250,639 was made by Buffie Craig A on Monday, January 22. On Thursday, October 26 the insider Paine Andrew J III sold $869,610.
Investors sentiment decreased to 1.1 in 2017 Q3. Its down 0.08, from 1.18 in 2017Q2. It is negative, as 46 investors sold KEY shares while 196 reduced holdings. 67 funds opened positions while 200 raised stakes. 841.58 million shares or 1.81% less from 857.12 million shares in 2017Q2 were reported. Commonwealth National Bank & Trust Of Aus reported 157,594 shares. Tributary Cap Mgmt Limited Liability Corporation has invested 0.21% of its portfolio in KeyCorp (NYSE:KEY). Beese Fulmer Investment Mngmt reported 73,314 shares. Axiom International Invsts De has 0.77% invested in KeyCorp (NYSE:KEY). 10,629 are owned by Parkwood Ltd Co. First Quadrant LP Ca stated it has 0% in KeyCorp (NYSE:KEY). Symphony Asset Mngmt Ltd Co has invested 0.1% in KeyCorp (NYSE:KEY). South Carolina-based Greenwood Cap Assoc Ltd has invested 0.2% in KeyCorp (NYSE:KEY). Credit Suisse Ag invested 0.02% in KeyCorp (NYSE:KEY). 38,455 are held by Everence Cap Incorporated. Wellington Group Inc Limited Liability Partnership holds 139,944 shares or 0% of its portfolio. Verition Fund Mgmt Ltd Company owns 23,560 shares or 0.04% of their US portfolio. Acg Wealth reported 0.04% of its portfolio in KeyCorp (NYSE:KEY). Plante Moran Financial Ltd Company holds 0.02% of its portfolio in KeyCorp (NYSE:KEY) for 2,001 shares. Riverpoint Capital Management Ltd Liability Co holds 10,188 shares.
Iguana Healthcare Management Llc, which manages about $139.00 million and $179.14 million US Long portfolio, upped its stake in Cigna Corporation (NYSE:CI) by 9,000 shares to 26,500 shares, valued at $4.95M in 2017Q3, according to the filing. It also increased its holding in Biogen Inc (NASDAQ:BIIB) by 12,500 shares in the quarter, for a total of 20,000 shares, and has risen its stake in Ignyta Inc (NASDAQ:RXDX).
Investors sentiment decreased to 1.19 in 2017 Q3. Its down 0.65, from 1.84 in 2017Q2. It dropped, as 17 investors sold RARE shares while 40 reduced holdings. 15 funds opened positions while 53 raised stakes. 39.75 million shares or 1.85% less from 40.50 million shares in 2017Q2 were reported. Ameritas Invest Prtnrs invested in 3,474 shares. State Board Of Administration Of Florida Retirement Systems holds 0% or 24,322 shares in its portfolio. Credit Suisse Ag invested 0.01% in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE). State Street holds 0.01% or 1.52 million shares. Blackrock has 0.01% invested in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) for 3.76M shares. Hood River Capital Mngmt Limited Liability invested in 0.39% or 114,294 shares. Cap Guardian Tru holds 0.48% or 521,035 shares. Nationwide Fund Advsr owns 57,314 shares. Smith Asset Mgmt Group LP stated it has 0.02% in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE). Parametric Port Associates Limited Liability Company stated it has 0% of its portfolio in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE). Eagle Asset Management holds 0.16% or 475,875 shares. Td Asset Mgmt Inc has 31,628 shares for 0% of their portfolio. Bnp Paribas Arbitrage invested 0% in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE). Columbia Wanger Asset Mngmt Ltd Com accumulated 1.60M shares or 1.26% of the stock. Capital International Ca has invested 0.36% of its portfolio in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE).